ProCE Banner Series

Viral Hepatitis and PBC Update: CCO Independent Conference Coverage of EASL 2025*

In this comprehensive program, including a live webinar, enduring webcast, downloadable slideset, and ClinicalThought commentaries written by experts in the field, learners will adopt new strategies for the management of viral hepatitis and PBC based on impactful data presented at EASL 2025.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

  ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, nurses, pharmacists, and other healthcare professionals involved in the care of patients with viral hepatitis or PBC.

All Events

Viral Hepatitis and PBC Update: CCO Independent Conference Coverage of EASL 2025*

Upcoming Events

May

13

2025

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Topics

Primary Biliary Cholangitis, Hepatitis B Virus, Hepatitis C Virus, Hepatitis Delta Virus

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners' competence in translating the most clinically important data from EASL 2025 into practical management strategies for patients with viral hepatitis or PBC.

Target Audience
This activity is intended for physicians, including hepatologists and gastroenterologists, nurse practitioners, nurses, pharmacists, and other healthcare professionals involved in the care of patients with viral hepatitis or PBC.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Incorporate the results of recent clinical studies of HBV and HDV management strategies into current and future clinical practice

  • Implement new data on optimizing HCV care, including unique approaches in priority populations

  • Evaluate the impact of recent clinical studies of PBC on current and future patient management strategies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-25-112-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit ACCME | CME Passport to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by an educational grant from Gilead Sciences, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191